RLAY Relay Therapeutics, Inc.
Relay Therapeutics, Inc. (RLAY) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 8% planned / 92% discretionary
Largest single sale: $116.4M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv | President and CEO | Sell 10b5-1 | 48,199 | $18.94 | $912.9K | 519,500 −8.5% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell 10b5-1 | 17,717 | $18.94 | $335.6K | 122,851 −12.6% of holding | |
| Bergstrom Donald A | President, R&D | Sell 10b5-1 | 8,530 | $18.97 | $161.8K | 399,130 −2.1% of holding | |
| Rahmer Peter | See remarks | Sell 10b5-1 | 4,508 | $20.03 | $90.3K | 223,657 −2% of holding | |
| Sell | 6,000,000 | $19.40 | $116.4M | 21,904,963 −21.5% of holding | |||
| Patel Sanjiv | President and CEO | Sell 10b5-1 | 48,199 | $20.33 | $979.9K | 567,699 −7.8% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell 10b5-1 | 17,717 | $19.74 | $349.7K | 140,568 −11.2% of holding | |
| Bergstrom Donald A | President, R&D | Sell | 2,237 | $18.61 | $41.6K | 407,660 −0.5% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell | 1,459 | $18.61 | $27.2K | 158,285 −0.9% of holding | |
| Rahmer Peter | See remarks | Sell | 748 | $18.61 | $13.9K | 228,165 −0.3% of holding | |
| Patel Sanjiv | President and CEO | Sell 10b5-1 | 48,199 | $19.58 | $943.7K | 615,898 −7.3% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell 10b5-1 | 17,717 | $18.69 | $331.1K | 159,744 −10% of holding | |
| Bergstrom Donald A | President, R&D | Sell 10b5-1 | 8,660 | $18.71 | $162.0K | 409,897 −2.1% of holding | |
| Rahmer Peter | See remarks | Sell 10b5-1 | 50,000 | $19.09 | $954.5K | 225,857 −18.1% of holding | |
| Catinazzo Thomas 4 fills | Chief Financial Officer | Sell 10b5-1 | 187,163 | $16.97 | $3.2M | 177,461 −51.3% of holding | |
| Bergstrom Donald A | President, R&D | Sell 10b5-1 | 93,456 | $16.94 | $1.6M | 418,557 −18.3% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.